Rahul Sidhu

Experts / Rahul Sidhu

PhD Candidate, Neuroscience, University of Sheffield

I study neurovascular coupling, which is the link between blood flow and neural activity in the brain. When your brain cells become active they require a constant supply of blood to meet the increasing energy demands. My research uses pre-clinical models of human disease to characterise neurovascular function in dementia, and how cardiovascular disease affects the speed, severity, and progression of Alzheimer’s disease. In the hope that we may be able to decelerate the progression of Alzheimer’s disease.

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Participants with genetic mutations but no cognitive issues at the start of treatment were significantly less likely to develop symptoms...

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Participants with genetic mutations but no cognitive issues at the start of treatment were significantly less likely to develop symptoms...

By Rahul Sidhu

Clinical Articles

Geriatric medicine, Neurology

Rahul Sidhu

PhD Candidate, Neuroscience, University of Sheffield

More from this expert

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Participants with genetic mutations but no cognitive issues at the start of treatment were significantly less likely to develop symptoms...

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Participants with genetic mutations but no cognitive issues at the start of treatment were significantly less likely to develop symptoms...

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Rahul Sidhu

PhD Candidate, Neuroscience, University of Sheffield

More from this expert

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Participants with genetic mutations but no cognitive issues at the start of treatment were significantly less likely to develop symptoms...

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Participants with genetic mutations but no cognitive issues at the start of treatment were significantly less likely to develop symptoms...

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.